Abstract Details

Title Botulinum Toxin Type a for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

Topic Headache and Pain

Presentation(s) (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Jun Hong Lee, MD	No disclosure on file
Rouzbeh Fateh, MD (Stanford HealthCare)	No disclosure on file
Hammad A. Bokhari, DO (UTHealth)	Dr. Bokhari has nothing to disclose.
John W. Lindsey, MD (University of Texas Health Science Center At Houston)	Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.